NSPRZ
NASDAQ
InspireMD Inc. Series B Warrants
Overview
NSPRZ
Symbol
NASDAQ
Exchange
About stock

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms.

The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel. Address: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832

InspireMD Inc. Series B Warrants dividend calculator
Report issue